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Introduction
Identification of the human genetic health
hazard from exposure to chemicals of a di-
verse nature is of significant importance
from a public health standpoint. A wide
variety of organisms ranging from phage
to human cells in culture may be used as
tester strains to identify the mutagenic cap-
ability of a chemical. While these systems do
supply genetically useful information, their
major limitation is their inability to con-
sider host biotransformation and other phar-
macokinetic parameters. This is of especial
importance if the derived data is to have
human relevance. While the most ideal situa-
tion would be to study man himself, the
major limitation to this approach would be
of a practical and ethical nature.
Short of studying man, then, in vivo mam-
malian indicator cells would have some ob-
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vious advantages. The L5178Y murine leu-
kemia has been relatively unexplored in the
area of mutagenicity testing but it has a
number of favorable attributes which en-
hance its utility as an indicator organism.
These are as follows: (1) It- grows well
in vitro as a single cell suspension- with a
doubling time in the range of 10-12 hr (1).
(2) By a relatively simple technique it-can
be cloned in soft agar with a plating efficiency
of approximately 60-90%-with the appear-
ance of macroscopic colonies within 10-14
days (2). (3) When implanted into the per-
itoneal cavity of certain inbred strains of
mice, it grows in a reproducible fashion as a
single cell-ascites suspension (1). (4) It has
been shown to require an exogenous supply
of the amino acid asparagine (asn) (3).
Thus by cloning the cells in asn-deficient
medium, spontaneous or induced mutations
to asn-independence can be scored. (5) It
possesses a uniform and stable chromosomal
complement with a modal number of 42
chromosomes (Fig. 1). (6) It can- be har-
vested from metastatic foci, enabling the
study of various organs at risk.
The present communication^ will -sum-
marize our methods for-in vitro and in vivo
propagation, the spontaneous mutation rate
to asn-independence, the properties of the
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FIGURE 1. Karyotype of L5178Y/asn- ascites cells.
newly derived mutants and the results of
mutation induction with known chemical
mutagens. The data represent a compilation
of experiments independently performed in
two separate laboratories (RLC and WPS)
by using slightly different techniques and
serve to illustrate the reproducibility of
studies with this genetic marker. Much of
the present material has been published pre-
viously (4-8).
Methods
Cell Propagation in Vitro
The L5178Y/asn- cell line which was used
in both laboratories was obtained in 1969
from Dr. G. A. Fischer. The cells were
grown in Fischer's medium (1) contain-
ing 10 mg/l. of L-asn (designated F+ medium)
and supplemented with 10%7o horse serum
(designated S,0) when grown in suspension
culture or with 15%o serum (S15) when cloned
in soft agar. Stock cultures were maintained
in continuous exponential growth (doubling
time 10-11 hr) by serial dilution two or three
times a week. These cultures were main-
tained in 16 x 125 mm screw-cap tubes in
a volume of 5 ml. The cell titer was kept
below 4 x 105/ml in order to prevent any
loss of viability (9) or possible enrichment
with mutants as the cells enter the station-
ary phase of growth.
Asn-less Fischer's medium (F- medium)
was used for the selective growth and clon-
ing of asn-independent cells (L5178Y/asn+).
The asn concentration of undialyzed horse
serum was previously determined (10) to be
approximately 1-2 mg/l. Thus, the final asn
concentration in F-S1o was 0.1-0.2 mg/l.
This level is 1-2%o of the concentration of
asn required for optimal growth of the
L5178Y/asn- cells (3). In F-S10 medium, the
cells stop dividing almost immediately and
begin to lyse within 24 hr. However, if
dialyzed serum is used, lysis begins within
6 hr (7).
Larger volumes of cells can be grown
under stationary or roller-cell conditions. If
stationary conditions are used, optimal
growth can occur in 29-oz rectangular pre-
scription bottles kept in the horizontal posi-
tion. Alternatively, if circular bottles are
used, continuous agitated suspension at 6
rpm has been satisfactory with the use of
New Brunswick Roller-cell equipment, RC-
42 (New Brunswick Scientific Company,
New Brunswick, N.J.).
Horse serum and media were purchased
from the Grand Island Biological Company,
Grand Island, N. Y., and from Microbiolo-
gical Associates, Bethesda, Md. Prior to pur-
chase, new lots of serum were tested for
their ability to support optimal cell growth
in suspension culture in addition to provid-
ing optimal cloning efficiencies.
Cell Propagation in Vivo
Both the parental L5178Y/asn- cells and
mutant L5178Y/asn+ substrains grow well
as single-cell ascites suspensions in certain
inbred strains of mice, notably the BDF,
and AKD2F, and the strain of origin,
DBA. For the in vivo experiments, male
BDF, mice were purchased from the Jackson
Laboratory, Bar Harbor, Maine, when they
weighed 18-20 g and were used for experi-
ments when they weighed approximately 25
g. Stock lines of the L5178Y cells in vivo
were initiated by intraperitoneal injection of
1 x 106 cells from in vitro cultures and
maintained by transplantation of 106f cells
(0.1 ml of a suspension containing 107 cells/
ml) to new host mice at weekly intervals
(1).
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included in the stock transfer which may
lead to enrichment of the stock line with
L5178Y/asn+ cells. This problem can be eli-
minated by transferring 104 cells in the
stock lines at weekly intervals. It is im-
portant to monitor the mouse lines for mu-
tant frequency at periodic intervals to en-
sure a low background mutant frequency in
the mutagenesis experiments.
Cloning Procedures
The soft agar cloning technique as de-
scribed by Chu and Fischer (2) was used
with some modifications for the determina-
tion of cell viability and frequency of asn-
independent mutant cells. Fischer's medium
with 15% horse serum was warmed to
37°C and added to the melted Noble agar
(50 ml into 5 ml water with 0.11 g agar)
which had been cooled to approximately 441C
(the temperature at which the concentrated
agar solidifies). The final agar-medium mix-
ture (0.2%o) can be kept at 37°C until used,
eliminating the need for use of a 44°C bath
as described in the original procedure. Pro-
longed incubation of this medium in loosely
capped containers or with small volumes in
large containers should be avoided, since the
pH increases as CO2 escapes.
For cloning in 16 x 125 mm culture tubes,
3 ml of the 0.2%o agar-medium mixture (at
37°C) and 2 ml of cell suspension (cells
diluted in FS,,) were added to the tubes at
room temperature; the tubes were capped,
inverted several times to mix the cells in the
medium, then placed upright in an ice-bath
for 3-5 min to gel the agar, thereby entrap-
ping the cells in suspension. The cultures
were then incubated in the upright position
at 37°C. Alternatively, 6 ml of the agar-
medium mixture and 4 ml of cell suspension
were added to 30-ml Falcon plastic flasks,
mixed gentlv, and the flasks placed in
crushed ice for 5 min. The flasks were then
incubated in the upright position.
Good cloning results are dependent on care-
ful control of the pH during development of
the clones. The medium should be at approx-
imately pH 7.0 at the time of cloning. This
may be achieved by adjustment of the pH of
the medium when prepared from powder or
concentrate (with storage in tightly capped
containers to prevent loss of CO2), or by
addition of sterile OJN HC1 to the medium
at the time of cloning to bring the medium
to a yellow-orange color. Clones develop with
poor efficiency when CO2 is lost and cultures
become alkaline. Thus, the cultures must be
tightly capped or incubated in a 5%o CO2 in-
cubator. With careful technique, 70-90%
cloning efficiency was routinely obtained.
Determination of the asn-independent mu-
tant frequency was performed in a similar
manner, except that F-S1, medium was used,
and a total of 2.5-5.0 x 105 cells were
cloned in the 5-ml cultures, or 5 x 108 cells
in 15 ml in the 30-ml Falcon flasks. Recon-
struction experiments indicated that the plat-
ing efficiency and recovery of mutants were
not affected until the concentration of cells
exceeded 5 x 105 per 5 ml culture, or 7
x 106 per 15 ml culture in the Falcon
flasks.
For the in vivo studies, ascites cells were
removed aseptically by injecting 5 ml of
F-S1o through the exposed peritoneum and
aspirating as much fluid as possible. The sus-
pension was diluted to 50 ml, centrifuged at
room temperature for 10 min at 250g, and the
cells were washed twice with F-S15. Finally,
the cell pellet was diluted with sufficient
F-S15 to provide a cell titer of 5 x 106/6
ml.
L5178Y/asn+ colonies which appeared
under these conditions grew as rapidly as
clones of the L5178Y/asn- line when cloned
in F+S,5. Under optimal conditions, the
colonies become visible without magnification
within 4-5 days and preliminary counts can
be made at about 7 days. Final counts are
determined at later times (10-14 days) when
the number of clones does not increase
further. The mutant frequency was expressed
as the number of mutants per 106 viable
cells, viability being determined by cloning
the cells in F+S,5.
When asn-less medium and undialyzed
serum are used for the determination of
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develop. However, colonies composed of
L5178Y/asn+ cells are easily distinguished
by virtue of their rapid growth, forming
large spherical colonies. Cells isolated from
the microcolonies and grown in F+S.0 did not
grow in F-S10. Furthermore, these did not
appear when dialyzed serum was used for
the cloning. These small colonies are ap-
parently asn-dependent cells able to grow for
a few generations in suboptimal asn con-
centrations. Nevertheless, the use of dialyzed
serum is not advisable because of the vari-
able and lower cloning efficiencies that are
obtained.
Growth of the-L5178Y/asn+ Substrains
L5178Y/asn+- cells derived from clones in
F-S15 are immediately able to grow in asn-
free m-edium with approximately the same
doubling time, as the parental, L5178Y/asn-
line. Thus, clones which arise under these
conditions can be tested for asn independ-
ence by picking the clone out of the culture
with a sterile Pasteur pi-pet and suspending
the cells in 5 ml of F-S -. Under these con-
ditions, L5178Y/asn- cells fail to grow and
soon begin to lyse, while cells from an
L5178Y/asn+ clone grow about as rapidly as
when a comparable number of cells from
culture are diluted to this concentration.
For example, clones picked at 7 days, contain-
ing approximately 5 x 104 cells, typically
yielded 2 to 3 x 106 cells after three days
growth, indicating an average doubling time
of no more than 12 hr. This method can be
used as a rapid screen to verify that the
clones observed are asn+ mutants, since rapid
growth (asn+ cells) versus cell lysis (asn-
cells) is easily determined by simple observa-
tion of the cultures.
Asparagine Synthetase- Assays
Two methods of measurement of the cap-
acity of various L5178Y/asn+ mutant cell
lines-for asn synthesis were used in previous
reports (6,7). The methods for measurement
of t-h-e level of asn synthetase activity in sub-
cellular preparations and of the accumulation
of asn during short-term incubation of whiole
cells at high density were previously de-
scribed by Chou and Handschumacher (11).
Results
The spontaneous mutation rate to asn
independence was determined by using the
fluctuation test as described by Luria and
Delbruck (12). By using eq. (8) of Luria and
Delbruck (11) with the aid of tables as
described by Capizzi and Jameson (13), the
in vitro mutation rate of L5178Y/asn- to
L5178Y/asn+ was found to be 7.4 and 9 x
10-7/cell/generation in two independent in-
vestigations (RLC and WPS, respectively).
Fluctuation tests performed with clones
adapted to in vivo growth yielded a muta-
tion rate of 9.9 x 10-7/cell/ generation.
Mutations to asn independence have been
induced by mutagens known to produce
either base pair substitution or frameshift
mutations. Dose-response data for the bi-
functional alkylating agent sulfur mustard
(SM) are shown in Table 1. L5178Y/asn-
cells were plated in F-S15 immediately after
30 min of exposure to sulfur mustard. A
nonlethal dose of SM (0.001 ug/ml) failed to
increase the mutant frequency. However, as
cytotoxicity increased, so did the mutant
frequency.
The induction of mutation with other
known mutagens is shown in Table 2.
L5178Y/asn- were exposed to various agents
in vitro, then washed and incubated in fresh,
Table 1. Sulfur mustard-induced mutants to
asparagine independence assayed on day
of treatment.a
MF x 10 survivors
Dose,
,ug/ml Control Treated
0.001 6.4 8.3
1.5 3.0
0.02 11.3 15.9
0.06 1.6 23.7
0.12 1.2 155.8
1.6 143.4
a L5178Y/asn- were exposed to sulfur mustard for
30 min, washed twice, then cloned for the determina-
tion of viability and mutant frequency (MF).
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Mutants per
Exposure Viability Expression 106 viable
Agent Dose, M time, hr % time, hr cells b
Control
MNNG 5 x 10-7 2 17 45 2.6 (5)
Control 2.1 (2)
EMS 6 x 103 2 38 45 23 (2)
Control 0.9 (2)
EMS 10-2 2 24 42 13 (2)
Control 1.5 (5)
ICR-372 2 X 10- 20 18 48 24.9 (5)
a After exposure of the L5178Y/asn- to the designated agents the cells were washed twice and re-
suspended in F+Sio. Following an "expression" time the cells were washed then cloned for viability and mu-
tant frequency.
b ( ) Numbers in parentheses, indicate the number of replicate determinations.
complete medium for 42-48 hr to allow "ex-
pression" of the mutation prior to cloning in
the selection medium (F-S15). An increase in
mutant frequency was produced by the alky-
lating agents ethyl methanesulfonate (EMS)
and N-methyl-N'-nitro-N-nitrosoguanidine
(MNNG) as well as the frameshift mutagen
ICR-372, 2-methoxy-6-chloro-9-[3-(2-chloro-
ethyl)aminopropylamino]1-azaacridine dihy-
drochloride.
The utility of the host-mediated assay
with the use of the L5178Y ascites tumor
is indicated with studies with dimethyl
nitrosamine (DMNA). Four days after the
intraperitoneal implantation of the L5178Y/
asn-, the mice were treated with a single sub-
cutaneous dose of DMNA. At 6 and 96 hr
after treatment, the cells were harvested,
washed twice with F-S15, and cloned for
viability in F+S15 and for mutant frequency
in F-S15. As is shown in Figure 2, when the
cells were assayed 6 hr after treatment, no
increase in mutants was produced by 2.5
mg/kg, and only a slight increase was pro-
duced by 5 and 10 mg/kg. However, when
the cells were assayed 4 days after treat-
ment, doses of 2.5, 5, and 10 mg/kg increased
the mutant frequency by 33, 160, and 900,
respectively. Comparable exposure of the
L5178Y/asn- to DMNA in vitro failed to
produce any cytotoxic or mutagenic effects.
Other known mutagens, EMS, MMS, and
MNNG, were also effective in increasing the
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FIGURE 2. DMNA-induced mutants to asn-independ-
ence. Mice were treated with a single subcutaneous
dose of DMNA 4 days after the intraperitoneal
implantation of 10' L5178Y/asn- cells. Cells were
harvested from the mice and cloned for viability
and mutant frequency at 6 hr (day 0 assay) and 4
days (day 4 assay) after treatment.
asn+ frequency when administered in the host
mediated assay.
In order to be sure that neither the auxo-
troph nor the prototroph was at an advant-
age or disadvantage to each other because of
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sublines were tested with equivalent doses of
each chemical and no significant differ-
ence was observed.
Spontaneous asn+ mutants have been stud-
ied in detail with respect to growth kinetics
and asparagine synthetase levels (7). Al-
though asn+ clones extracted from F-S15 grow
at near the optimal rate in F-S10 upon serial
passage, it was repeatedly observed that the
growth rate was not identical to the L5178Y/
asn- for the first few weeks passage in the
asn-less medium. To further characterize the
properties of newly derived spontaneous mu-
tants, clonal isolates were maintained under
nonselective conditions (i.e., in F+S1O) except
during the selective cloning step. This pro-
cedure revealed that the initial mutation does
not impart total asn independence. This is
evident by a slower, nonpopulation-dependent
growth rate (20-24 hr) of the cells when
subcultured in asn-less medium. They re-
sume the 10-11 hr doubling time within
16-24 hr. This was observed in the newly
isolated clones and has remained unchanged
after many passages in F+S,o. The serial
passage of mutant substrains in F-S,O pro-
duced asn+ lines whose growth was identical
in the presence and absence of asn.
The specific activity of the enzyme, as-
paragine synthetase, correlated with these
cell growth patterns. The enzyme activity
in newly isola-ted clones and in the progeny
of mutant clones maintained in F+S1. for
periods in excess of a year was approximate-
ly 4 nmole/mg protein/hr compared to <0.7
nmole/mg protein- hr in the parental,
L5178Y/asn- cells. However, the increase in
growth rate after continuous subculture in
F-S0n was associated with a significant in-
crease in the asn synthetase activity (15-30
nmole asn/mg protein-hr in various fully
adapted asn+ lines). This level was not de-
creased by growing the cells in asn-supple-
mented medium (F+S1o).
Thus the original mutation is to an in-
termediate level of asn synthetase and the
further transition to complete asn-independ-
ence may require further mutation and selec-
tion. Growth studies and asn synthetase as-
says on mutants induced by MNNG, EMS,
and ICR-372 indicated that these mutants
had the same characteristics as the ini-
tial spontaneous mutants.
Discussion
The applicability and utility of various
nonmammalian and mammalian tester
strains for the detection of chemical muta-
gens have been discussed in several recent
texts (14-16). Although the L5178Y murine
leukemia has not been extensively investi-
gated, several recent reports have indicated
the applicability of the thymidine kinase
locus (17) and resistance to MTX, Ara-c and
IUDR (18) as genetic markers for the detec-
tion of chemical mutagens.
The susceptibility of the asn locus to mu-
tation by chemicals known to produce frame-
shift mutations and mutations by base-pair
substitutions suggests that the observed
change in phenotype from auxotrophy to
prototrophy might not be a "reverse" muta-
tion but rather a "forward" mutation involv-
ing the inactivation of a repressor or inhi-
bitor. This observed mutability of the asn
locus by known chemical mutagens warrants
further exploration.
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